산화질소 생성 억제용 피라졸로피리미딘 유도체 화합물
    14.
    发明公开
    산화질소 생성 억제용 피라졸로피리미딘 유도체 화합물 有权
    吡唑并嘧啶衍生物,抑制生产氮氧化物的组合物和药物组合物,用于预防和治疗包括其的疾病

    公开(公告)号:KR1020130112248A

    公开(公告)日:2013-10-14

    申请号:KR1020120034483

    申请日:2012-04-03

    Abstract: PURPOSE: A composition containing a pyrazolopyrimidine derivative compound for suppressing NO generation and a pharmaceutical composition containing the pyrazolopyrimidine derivative compound for preventing and treating neurological disorders are provided to suppress NO generation in vivo and to treat neurological disorders caused by functional disturbance and apoptosis of neural cells. CONSTITUTION: A pyrazolopyrimidine derivative compound of chemical formulas I-VII or a pharmaceutically acceptable salt thereof is provided. A pharmaceutical composition for suppressing NO generation contains a pharmaceutically acceptable carrier or diluent and the compounds as active ingredients. A composition for treating neurological disorders contains the pharmaceutically acceptable carrier or diluent and the compounds as active ingredients. The neurological diseases are selected among Parkinson's disease, Alzheimer's disease, Huntington's disease, amylotrophic lateral sclerosis, epilepsia, depression, pain, anxiety, and neurodegenerative diseases.

    Abstract translation: 目的:提供含有用于抑制NO产生的吡唑并嘧啶衍生物化合物和含有吡唑并嘧啶衍生物化合物用于预防和治疗神经障碍的药物组合物,用于抑制体内NO产生并治疗由神经细胞的功能紊乱和细胞凋亡引起的神经障碍 。 构成:提供化学式I-VII的吡唑并嘧啶衍生物化合物或其药学上可接受的盐。 用于抑制NO生成的药物组合物含有药学上可接受的载体或稀释剂,作为活性成分的化合物。 用于治疗神经障碍的组合物含有药学上可接受的载体或稀释剂,并且所述化合物作为活性成分。 神经系统疾病选自帕金森病,阿尔茨海默病,亨廷顿病,肌营养性侧索硬化,癫痫,抑郁,疼痛,焦虑和神经变性疾病。

Patent Agency Ranking